Browse All

Current Filters

CLEAR FILTER x

TITLE

Intermittent Theta Burst Transcranial Magnetic Stimulation Improves Language and Functional Connectivity in Primary Progressive Aphasia

Author:Paranhos, Thiago   Du, Anna   Nneka, Watson   Hochberg, Daisy   Quimby, Megan   Rezaii, Neguine   Wong, Bonnie   Katsumi, Yuta   Dickerson, Bradford   Eldaief, Mark   Touroutoglou, Alexandra   

Session Name:S23: Innovations in Dementia Treatment  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S23.009  

Author Institution:Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA  

The Temporal Landscape of Age-Related Short Tandem Repeat Triggered Neurodegeneration

Author:Albertson, Richard   Cheng, Abby   Todd, Peter   

Session Name:N1: Neuroscience in the Clinic: Repeat Expansion Disorders in Neurological Disease  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:N1.002  

Author Institution:University of Michigan, Ann Arbor, MI  

Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment

Author:Yu, Jin-Tai   

Session Name:N4: Neuroscience in the Clinic: Time for Tau: Developments in Biomarkers and Therapeutic Trials  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:N4.001  

Author Institution:Huashan Hospital, Fudan University, Shanghai, China, People's Republic of  

Whole-brain functional connectivity predicts tau PET in preclincal Alzheimer’s disease

Author:Abuwarda, Hamid   Trainer, Anne   Horien, Corey   Shen, Xilin   Ju, Suyeon   Constable, Todd   Fredericks, Carolyn   

Session Name:N4: Neuroscience in the Clinic: Time for Tau: Developments in Biomarkers and Therapeutic Trials  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:N4.002  

Author Institution:Yale School of Medicine, New Haven, CT  Yale School of Medicine, Baltimore, MD  

Evaluation of Plasma pTau217 plus Abeta42/40, and pTau217/Abeta42 Ratio as Confirmatory Tests for Amyloid Pathology in Alzheimer’s Disease (AD)

Author:Winslow, John   Chenna, Ahmed   Lo, Mintzu   Badal, Youssouf   Yee, Brandon   Martone, Robert   Petropoulos, Christos   Fowler, Christopher   Laws, Simon   Rainey-Smith, Stephanie   Martins, Ralph N   Rowe, Christopher   Masters, Colin   Doecke, James D   

Session Name:N4: Neuroscience in the Clinic: Time for Tau: Developments in Biomarkers and Therapeutic Trials  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:N4.003  

Author Institution:Labcorp/Monogram Biosciences, South San Francisco, CA  Labcorp/Monogram Biosciences , South San Francisco, CA  Labcorp Drug Development, Indianapolis, IN  The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia  Centre for Precision Health, Edith Cowan University, Joondalup, Australia  Centre for Healthy Ageing, Murdoch University, Murdoch, Australia  Edith Cowan University, Joondalup, Australia  The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia  The Australian e-Health Research Centre, CSIRO, Brisbane , Australia